HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cobalt-chromium KAname™ coRonary stEnt system in the treatment of patients with coronary artery disease (KARE study).

AbstractOBJECTIVES:
To evaluate the safety and effectiveness of the Kaname™ cobalt-chromium (Co-Cr), thin strut, bare metal stent (BMS) system for the treatment of coronary artery lesions.
BACKGROUND:
Despite widespread use of drug-eluting stents, a certain percentage of patients with coronary artery disease are still treated with BMS. Therefore, it is essential to evaluate their clinical performance.
METHODS:
Two hundred eighty-two patients were enrolled in this prospective, single-arm study including a predefined subset of 79 patients with small vessels. The primary end-point was freedom from target vessel failure (TVF) at 6 months. Key angiographic and intravascular ultrasound (IVUS) end-points were late loss, diameter stenosis, binary restenosis, and neointimal hyperplasia volume.
RESULTS:
Freedom from TVF at 6 months was 93.3% and at 1 year 90.8% in total population, and 92.4% and 87.3% in small vessels, respectively. Clinically driven target lesion revascularization (TLR) rates at 6 and 12 months were 4.3% and 6.4% in total population, and 3.8% and 7.6% in small vessels, respectively. At 6 months in-stent late loss was 0.75 ± 0.43 mm and binary restenosis rate was 16.9% in total population, and 0.64 ± 0.40 mm and 26.1% in small vessels, while IVUS assessed neointimal hyperplasia volume at 6 months was 128.9 ± 42.6 mm(3) for total population. There were no definite and probable stent thromboses up to 12 months.
CONCLUSIONS:
Results indicate good safety and effectiveness of the Kaname™ stent with clinically equivalent results in small and larger vessels, as such providing useful treatment option for patients with ischemic heart disease considered for BMS implantation.
AuthorsDidier Carrie, Volker Schächinger, Gian Battista Danzi, Carlos Macaya, Uwe Zeymer, Biljana Putnikovic, Andres Iniguez, Raul Moreno, Zlatko Mehmedbegovic, Branko Beleslin, KARE INVESTIGATORS
JournalJournal of interventional cardiology (J Interv Cardiol) Vol. 27 Issue 5 Pg. 491-9 (Oct 2014) ISSN: 1540-8183 [Electronic] United States
PMID25175153 (Publication Type: Clinical Trial, Journal Article)
Copyright© 2014, Wiley Periodicals, Inc.
Chemical References
  • Chromium
  • Cobalt
Topics
  • Aged
  • Angioplasty, Balloon, Coronary
  • Chromium
  • Cobalt
  • Coronary Angiography
  • Coronary Artery Disease (therapy)
  • Coronary Restenosis (epidemiology)
  • Female
  • France (epidemiology)
  • Humans
  • Hyperplasia
  • Male
  • Middle Aged
  • Neointima (pathology)
  • Prospective Studies
  • Stents

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: